AquaLumen for Open-Angle Glaucoma
This study is testing a new, implant-free, minimally invasive surgery called AquaLumen for people with moderate to severe open-angle glaucoma. Glaucoma is an eye condition that can damage your vision. The AquaLumen procedure aims to lower the pressure inside your eye (intraocular pressure or IOP). Researchers will follow 10 participants for one year to see how well AquaLumen lowers IOP and if it reduces the need for glaucoma eye drops. To join, you must be 18 or older and have moderate to severe open-angle glaucoma with a specific central corneal thickness. You cannot have had a corneal graft, corneal opacities, or a failed trabeculectomy (another type of glaucoma surgery). The current recruitment status is unclear.
- Study design
- This is an interventional study following a group of 10 participants. It is not specified if it is randomized or blinded.
- What's involved
- Participants will undergo the AquaLumen surgical procedure and be followed for one year.
- Compensation
- Not stated in the trial record.
- Follow-up
- Participants will be followed for 12 months after the procedure to measure eye pressure and medication use.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
A Prospective Interventional Cohort Study to Evaluate the Efficacy and Safety of the AquaLumen, a Novel Filtration Procedure for the Treatment of Open Angle Glaucoma
At a glance
Conditions
Where it's being run
1 sites across 1 statesWho to contact
Opens a ready-to-send draft in your own email app — review before sending.
Do you actually qualify for this trial?
Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.
Inclusion
Exclusion
What this trial measures
- Intra Ocular pressure12 months
- Use of concomitant topical glaucoma medications12 months